Clinical Trial Update: Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating metformin hydrochloride in combination with standard systemic therapy for previously untreated advanced unres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma
• Soft-tissue Sarcoma

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Sarcoma Metastatic, Sarcoma, Soft Tissue | Phase 2 | Status: RECRUITING